Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

October 26, 2018 11:20 AM | Anonymous

October 26, 2018, Cancer Research UK via Medical Xpress  

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new clinical trial results. The study, published in the New England Journal of Medicine, found that the drug olaparib (Lynparza) could delay the return of advanced ovarian cancer in some woman whose cancer cells carry a faulty BRCA gene, or stopped the disease from getting worse.

Read more.

Powered by Wild Apricot Membership Software